heart failure semaglutide in Patients with Obesity-Related and Type 2 Diabetes | NEJM Peanut Free Beyond Ozempic: New GLP-1 Size:10 x 10mg (one box)

heart failure semaglutide in Patients with Obesity-Related and Type 2 Diabetes | NEJM Peanut Free Beyond Ozempic: New GLP-1 Size:10 x 10mg (one box)

Beyond Ozempic: New GLP-1 Alternatives Expected in 2026 | What Patients Should Know

Key TakeawaysGLP-1 medications may increase the risk of low blood pressure eventsOlder adults and people with type 2 diabetes seem to be most vulnerablePatients already taking blood pressure medication should be closely monitored by their doctor.MONDAY, June 15, 2026 (HealthDay News) — Researchers are flagging a potential safety concern tied to GLP-1 medications and blood pressure.A new Northwestern Medicine study tracked more than 42,000 adults who started semaglutide, tirzepatide or liraglutide while taking multiple blood pressure drugs.The authors tracked hypotensive episodes, including dizziness, fainting, falls, low blood pressure diagnoses and very low blood pressure readings.The overall rate of these events jumped from 8.7% to 10.2% within six months of starting GLP-1 therapy, and remained significant at 12 months, the study found.The risk was highest in adults 65 and older and people with type 2 diabetes.Researchers also found the increase could not be explained by weight loss alone."I'm a big proponent of GLP-1s, they are huge

Peanut Free

Size:10 x 10mg (one box)

The researchers attributed those perks to the plant compounds in the hibiscus extract